Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 2, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 8
- −1 vs. Q1 2022
- Portfolio value
- $53.8M
- −$208.0M (−79.5%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PMVPPMV Pharmaceuticals, Inc. | COM | 1,614,911 | $23.0M | 42.8% | −1,620,000−50.1% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 351,244 | $16.0M | 29.7% | +980+0.3% | Added | History |
| REALTheRealReal, Inc. | COM | 2,354,080 | $5.86M | 10.9% | 00.0% | Unchanged | History |
| SERASera Prognostics, Inc. | CLASS A COM | 2,416,241 | $3.96M | 7.4% | 00.0% | Unchanged | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 560,990 | $3.53M | 6.6% | 00.0% | Unchanged | History |
| AGTCApplied Genetic Technologies Corp | COM | 1,404,515 | $1.08M | 2.0% | 00.0% | Unchanged | History |
| VEROVenus Concept Inc. | COM | 658,657 | $305.0K | 0.6% | 00.0% | Unchanged | History |
| DAREDare Bioscience, Inc. | COM | 62,065 | $76.0K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2022 (1)
Positions held at the end of Q1 2022 that are gone from this filing.